The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Medullary

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Medullary


Psychiatry related information on Carcinoma, Medullary


High impact information on Carcinoma, Medullary


Chemical compound and disease context of Carcinoma, Medullary


Biological context of Carcinoma, Medullary


Anatomical context of Carcinoma, Medullary


Gene context of Carcinoma, Medullary


Analytical, diagnostic and therapeutic context of Carcinoma, Medullary


  1. Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Takahashi, C., Contreras, B., Iwanaga, T., Takegami, Y., Bakker, A., Bronson, R.T., Noda, M., Loda, M., Hunt, J.L., Ewen, M.E. Nat. Genet. (2006) [Pubmed]
  2. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation. Kawai, K., Iwashita, T., Murakami, H., Hiraiwa, N., Yoshiki, A., Kusakabe, M., Ono, K., Iida, K., Nakayama, A., Takahashi, M. Cancer Res. (2000) [Pubmed]
  3. Senile cardiac amyloid: demonstration of a unique fibril protein in tissue sections. Cornwell, G.G., Natvig, J.B., Westermark, P., Husby, G. J. Immunol. (1978) [Pubmed]
  4. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. Holm, R., Nesland, J.M. J. Pathol. (1994) [Pubmed]
  5. Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A. Quadro, L., Panariello, L., Salvatore, D., Carlomagno, F., Del Prete, M., Nunziata, V., Colantuoni, V., Di Giovanni, G., Brandi, M.L., Mannelli, M. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  6. Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects. Dammacco, F. Ann. Ital. Med. Int. (1991) [Pubmed]
  7. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid. Anast, C., David, L., Winnacker, J., Glass, R., Baskin, W., Brubaker, L., Burns, T. J. Clin. Invest. (1975) [Pubmed]
  8. Clinical significance of plasma somatostatin determination in medullary carcinoma of thyroid. Saito, H., Saito, S. Lancet (1980) [Pubmed]
  9. Letter: Pentagastrin test in medullary carcinoma of the thyroid. Rasmusson, B. Lancet (1975) [Pubmed]
  10. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., Mandinova, A., Raffoul, W., Fiche, M., Dotto, G.P., Brisken, C. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  11. p53 mutations and histological type of invasive breast carcinoma. Marchetti, A., Buttitta, F., Pellegrini, S., Campani, D., Diella, F., Cecchetti, D., Callahan, R., Bistocchi, M. Cancer Res. (1993) [Pubmed]
  12. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115. Noguchi, S., Takatsuka, D., Kitamura, Y., Terada, N., Uchida, N., Yamaguchi, K., Sato, B., Matsumoto, K. Cancer Res. (1985) [Pubmed]
  13. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. Nakaigawa, N., Weirich, G., Schmidt, L., Zbar, B. Oncogene (2000) [Pubmed]
  14. Medullary carcinoma of the thyroid, pancreatic nesidioblastosis and microadenosis, and pancreatic polypeptide hypersecretion: a new association and clinical and hormonal responses to long-acting somatostatin analog SMS 201-995. Jerkins, T.W., Sacks, H.S., O'Dorisio, T.M., Tuttle, S., Solomon, S.S. J. Clin. Endocrinol. Metab. (1987) [Pubmed]
  15. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid. Lee, S., Morimoto, S., Onishi, T., Tsuji, M., Okada, Y., Seino, Y., Ishida, M., Yamaoka, K., Takai, S., Miyauchi, A., Kumahara, Y. J. Clin. Endocrinol. Metab. (1982) [Pubmed]
  16. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine. Clarke, S.E., Lazarus, C.R., Edwards, S., Murby, B., Clarke, D.G., Roden, T.M., Fogelman, I., Maisey, M.N. J. Nucl. Med. (1987) [Pubmed]
  17. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast. Yakirevich, E., Maroun, L., Cohen, O., Izhak, O.B., Rennert, G., Resnick, M.B. J. Pathol. (2000) [Pubmed]
  18. Analysis of the RET proto-oncogene in sporadic parathyroid adenomas. Williams, G.H., Rooney, S., Carss, A., Cummins, G., Thomas, G.A., Williams, E.D. J. Pathol. (1996) [Pubmed]
  19. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells. Dilla, T., Velasco, J.A., Medina, D.L., González-Palacios, J.F., Santisteban, P. Endocrinology (2000) [Pubmed]
  20. Point mutations of ras and Gs alpha subunit genes in thyroid tumors. Horie, H., Yokogoshi, Y., Tsuyuguchi, M., Saito, S. Jpn. J. Cancer Res. (1995) [Pubmed]
  21. Calcium metabolism evaluated by 47Ca kinetics: estimation of dermal calcium loss. Charles, P., Jensen, F.T., Mosekilde, L., Hansen, H.H. Clin. Sci. (1983) [Pubmed]
  22. Introduction of p53 induces cell-cycle arrest in p53-deficient human medullary-thyroid-carcinoma cells. Velasco, J.A., Medina, D.L., Romero, J., Mato, M.E., Santisteban, P. Int. J. Cancer (1997) [Pubmed]
  23. Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group. Neijt, J.P., Lacave, A.J., Splinter, T.A., Taal, B.G., Veenhof, C.H., Sahmoud, T., Lips, C.J. Br. J. Cancer (1995) [Pubmed]
  24. Immunohistochemical detection of cathepsin D in T2N0M0 breast carcinoma. Armas, O.A., Gerald, W.L., Lesser, M.L., Arroyo, C.D., Norton, L., Rosen, P.P. Am. J. Surg. Pathol. (1994) [Pubmed]
  25. Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Han, A.C., Soler, A.P., Knudsen, K.A., Salazar, H. Hum. Pathol. (1999) [Pubmed]
  26. Medullary carcinoma of the thyroid with atypical patterns. Bussolati, G., Monga, G. Cancer (1979) [Pubmed]
  27. Concomitant inactivation of p53 and Chk2 in breast cancer. Sullivan, A., Yuille, M., Repellin, C., Reddy, A., Reelfs, O., Bell, A., Dunne, B., Gusterson, B.A., Osin, P., Farrell, P.J., Yulug, I., Evans, A., Ozcelik, T., Gasco, M., Crook, T. Oncogene (2002) [Pubmed]
  28. Expression of the proopiomelanocortin gene in human medullary thyroid carcinoma. Steenbergh, P.H., Höppener, J.W., Zandberg, J., Roos, B.A., Jansz, H.S., Lips, C.J. J. Clin. Endocrinol. Metab. (1984) [Pubmed]
  29. Amylin/islet amyloid polypeptide expression in medullary carcinoma of the thyroid: correlation with the expression of the related calcitonin/CGRP genes. Alevizaki, M., Dai, K., Grigorakis, S.I., Legon, S., Souvatzoglou, A. Clin. Endocrinol. (Oxf) (1994) [Pubmed]
  30. Pancreatic polypeptide immunoreactivity in medullary carcinoma of the thyroid: identification and characterisation by radioimmunoassay, immunocytochemistry and high performance liquid chromatography. O'Hare, M.M., Shaw, C., Johnston, C.F., Russell, C.F., Sloan, J.M., Buchanan, K.D. Regul. Pept. (1986) [Pubmed]
  31. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Papotti, M., Kumar, U., Volante, M., Pecchioni, C., Patel, Y.C. Clin. Endocrinol. (Oxf) (2001) [Pubmed]
  32. Thyroglobulin in carcinoma of the thyroid: an immunohistochemical study. Albores-Saavedra, J., Nadji, M., Civantos, F., Morales, A.R. Hum. Pathol. (1983) [Pubmed]
  33. Immunoelectron microscopic demonstration of regulated pathway for calcitonin and constitutive pathway for carcinoembryonic antigen in the same cells of human medullary carcinomas of thyroid glands. Osamura, R.Y., Yasuda, O., Kawakami, T., Itoh, Y., Inada, K., Kakudo, K. Mod. Pathol. (1997) [Pubmed]
  34. Medullary carcinoma in children. Results of early detection and surgery. Telander, R.L., Zimmerman, D., Sizemore, G.W., van Heerden, J.A., Grant, C.S. Archives of surgery (Chicago, Ill. : 1960) (1989) [Pubmed]
  35. Glandular (tubular and follicular) variants of medullary carcinoma of the thyroid. Harach, H.R., Williams, E.D. Histopathology (1983) [Pubmed]
  36. E-cadherin and beta-catenin expression in breast medullary carcinomas. Charpin, C., Bonnier, P., Garcia, S., Andrac, L., Crebassa, B., Dorel, M., Lavaut, M.N., Allasia, C. Int. J. Oncol. (1999) [Pubmed]
WikiGenes - Universities